Latest Breaking News On - Alaunos therapeutics - Page 8 : vimarsana.com

Why Is Alaunos Therapeutics Sinking Today? - Alaunos Therapeutics (NASDAQ:TCRT)

Alaunos Therapeutics Inc (NASDAQ: TCRT) announced a strategic reprioritization to focus on its hunTR TCR discovery platform, wind down its TCR-T Phase 1/2 Library trial, and explore broad strategic 

Cantor fitzgerald coLibrary phaseAlaunos therapeuticsCantor fitzgerald

12 Health Care Stocks Moving In Tuesday s Intraday Session - Galecto (NASDAQ:GLTO), Healthcare Triangle (NASDAQ:HCTI), Tiziana Life Sciences (NASDAQ:TLSA), OptimizeRx (NASDAQ:OPRX), Bone Biologics (NASDAQ:BBLG), G Medical Innovations (NASDAQ:GMVD), Design Therapeutics (NASDAQ:DSGN), Alaunos Therapeutics (NASDAQ:TCRT), Assure Hldgs (NASDAQ:IONM), T2 Biosystems (NASDAQ:TTOO), Novo Integrated Sciences (NASDAQ:NVOS), Delcath Systems (NASDAQ:DCTH)

Alaunos therapeuticsDelcath systemsTiziana life sciencesNovo integrated sciencesLife sciencesMedical innovationsDesign therapeuticsAssure hldgs

Laidlaw Downgrades Alaunos Therapeutics to Hold From Buy

Price: 0.14, Change: -0.26, Percent Change: -65.07 . -Today at 10:42 am- MarketScreener

Alaunos therapeutics incAlaunos therapeuticsSleeping beauty

Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives

Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHeather andersonKevins boyleDown library phaseCompany library phaseAlaunos therapeutics inc statement of operationsLibrary phaseAlaunos therapeutics incCantor fitzgerald coRestructuring organizationDevelopment expensesCompany nasdaqNasdaq stock marketAlaunos therapeutics inc selected balance sheet dataExchange commissionSleeping beauty

Alaunos Therapeutics (TCRT) to wind down its TCR-T Library Phase 1/2 trial and prioritize the hunTR platform

Alaunos Therapeutics (TCRT) to wind down its TCR-T Library Phase 1/2 trial and prioritize the hunTR platform
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kevins boyleLibrary phaseAlaunos therapeutics incCantor fitzgerald coDevelopment expensesRestructuring organizationDown library phaseCompany library phaseCompany nasdaqAlaunos therapeuticsSleeping beautyChief executive officerClinical dataPlatform identifies proprietaryWinding downCantor fitzgerald